The Grant Review Panel strives to short-list proposals that are most relevant, innovative, and impactful. Only the strongest applications that offer the greatest potential to deliver new progress in the prevention of cancer, and improve outcomes through lifestyle modifications, will be funded to pursue their research. The process is highly competitive and rigorous. The Chair […]
Research in the Chapkin lab focuses on dietary/microbial modulators related to the prevention of cancer and chronic inflammatory diseases. The lab has been continuously funded by the National Institutes of Health (NIH) for the past 29 years.
Long-Chain n-3 Fatty Acids Attenuate Oncogenic KRas-Driven Proliferation by Altering Plasma Membrane Nanoscale Proteolipid Composition Natividad R. Fuentes1,2, Mohamed Mlih3, Rola Barhoumi4, Yang-Yi Fan1, Paul Hardin5, Trevor J. Steele6, Spencer Behmer6, Ian A. Prior7, Jason Karpac3, and Robert S. Chapkin1,8 Ras signaling originates from transient nanoscale compartmentalized regions of the plasma membrane composed of specific […]
Dr. Chapkin talks with cancerNetwork, home of the journal ONCOLOGY. “We have become very familiar with reports in the media comparing the health effects of Western diets, typically heavy in animal fats and proteins, with Asian and Mediterranean diets, which include more fish and place greater emphasis on consumption of fruits, vegetables, and whole grains. […]
On April 16, 2018 Huajun Han took home 2nd place at the Graduate Student Research Symposium in the Oral competition for his research titled, “Protective role of the aryl hydrocarbon receptor in regulating colonic stem and progenitor cell homeostasis.” This event is a one-day research symposium for students to share their work with fellow students, […]